Skip to main content
Premium Trial:

Request an Annual Quote

Revenues and Earnings Up for Thermo Electron in Q1

NEW YORK, April 28 (GenomeWeb News) - Thermo Electron yesterday reported increased revenues and earnings for the first quarter.


Revenues for the quarter were $582 million, up from $500.2 million during the same period last year. The Life and Laboratory Sciences segment, which includes mass spectrometers for proteomics, reported $365 million in revenues, up from $299 during the year-ago period. Thermo attributed the revenue growth in this segment mainly to strong sales of mass spectrometry and spectroscopy instruments.


Research and development expenses climbed slightly, to $39.8 million, from $37.3 million during last year's first quarter.


Earnings for the quarter were $43.1 million, or $.26 per share, up from $36.4 million, or $.22 per share, during the year-ago period.


As of April 3, Thermo had $353 million in cash and cash equivalents, and $91 million in short-term investments.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.